In This Section

CIMM Steering Committee

Catherine J. Wu, MD
Chair

Catherine J. Wu, MD

(2024-2026)

Professor of Medicine, Harvard Medical School
Chief, Division of Stem Cell Transplantation and Cellular Therapies
Dana-Farber Cancer Institute
Department of Medical Oncology
Lavine Family Chair for Preventative Cancer Therapies
Institute Member, Broad Institute of MIT and Harvard
Boston, Massachusetts

Ivan M. Borrello, MD

Ivan M. Borrello, MD

(2023-2026)

Director
Multiple Myeloma, BMT and Cell Therapy
Tampa General Hospital
Tampa, Florida

Joshua Brody, MD

Joshua Brody, MD

(2025-2028)

Director of the Lymphoma Immunotherapy Program
Icahn School of Medicine at Mount Sinai
Tisch Cancer Institute
Precision Immunology Institute
Icahn Genomics Institute
New York, New York

Julie R. Brahmer, MD, MSc, FASCO

Julie R. Brahmer, MD, MSc, FASCO

(2024-2027)

The Marilyn Meyerhoff Professor of Thoracic Oncology
Co-Leader of Cancer Immunology Research Program
Co-Director of the Upper Aerodigestive Cancers Program
Director of the Johns Hopkins Kimmel Cancer Center on the Bayview Campus
Baltimore, Maryland

Tullia C. Bruno, PhD

Tullia C. Bruno, PhD

(2024-2027)

Assistant Professor of Immunology
University of Pittsburgh
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

Myriam Chalabi, MD, PhD

Myriam Chalabi, MD, PhD

(2025-2028)

Medical Oncologist
Clinical Group Leader
Department of Gastrointestinal Oncology
Netherlands Cancer Institute
Amsterdam, Netherlands

John F. DiPersio, MD, PhD

John F. DiPersio, MD, PhD

(2023-2026)

Virginia E. and Samuel J. Golman Professor of Medicine
Professor of Medicine and Pathology & Immunology
Director, Center for Gene and Cellular Immunotherapy
Washington University School of Medicine
St. Louis, Missouri

Thomas F. Gajewski, MD, PhD

Thomas F. Gajewski, MD, PhD

(2024-2027)

AbbVie Foundation Professor of Pathology
Professor of Medicine
Professor of Ben May Department of Cancer Research
University of Chicago
Chicago, Illinois

Stephen Gottschalk, MD

Stephen Gottschalk, MD

(2024-2027)

Chair, Department of BMT & Cellular Therapy
St Jude Children’s Research Hospital
Memphis, Tennessee

Saar Gill, MBBS, PhD, FRACP

Saar Gill, MBBS, PhD, FRACP

(2025-2028)

Associate Professor of Medicine, Division of Hematology-Oncology
Director, Translational Center of Excellence in Genetically Engineered Hematopoietic Stem Cell Transplantation
Co-Director, Parker Institute for Cancer Immunotherapy
Scientific Director, Cell Therapy & Transplantation
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

Jennifer L. Guerriero, PhD

Jennifer L. Guerriero, PhD

(2023-2026)

Assistant Professor, Harvard Medical School
Lead Investigator, Brigham and Women’s Hospital
Member, Breast Cancer, Dana-Farber/Harvard Cancer Center
Member, Harvard Immunology, Harvard Medical School
Boston, Massachusetts

Susan Kaech, PhD

Susan Kaech, PhD

(2024-2027)

Professor and Director
NOMIS Center for Immunobiology and Microbial Pathogenesis
Salk Institute for Biological Sciences
La Jolla, California

Justin P. Kline, MD

Justin P. Kline, MD

(2025-2028)

Professor of Medicine
Biological Sciences Division
University of Chicago
Chicago, Illinois

Jeffrey S. Miller, MD

Jeffrey S. Miller, MD

(2023-2026)

Professor of Medicine
Section Head, BMT and Cell Therapy
Division of Hematology, Oncology and Transplantation
Deputy Director, Masonic Cancer Center
Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics
University of Minnesota
Minneapolis, Minnesota

Karolina Palucka, MD, PhD

Karolina Palucka, MD, PhD

(2023-2026)

Professor
Director of the JAX Cancer Center
The Jackson Laboratory for Genomic Medicine
Farmington, Connecticut

Rocío K. Rivera-Valentín, MD, PhD

Rocío K. Rivera-Valentín, MD, PhD

(2025-2028)

Pediatric Hematology-Oncology
Division of Clinical and Translational Cancer Research
University of Puerto Rico Comprehensive Cancer Center
San Juan, Puerto Rico